hGH fragment raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-20 and is reviewed periodically as new material appears.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
=== Ethnic groups === According to the 2021 census, ethnically the Bromley town ward was 70.1% White, 54.0% were White British, White Irish 1.7%, Roma 0.4% and 14.0% Other White. Asians were 12.8%, Black were 7.4%, mixed 6.7% and other were 3.0%.
=== Mauveine === Mauveine was discovered when Henry Perkin was trying to convert an artificial base into the natural alkaloid quinine. He tried adding aniline – a different base with a simpler construction. This created a black product. After purification, drying and washing with alcohol, Perkin had a mauve dye. Perkin filed his patent in August 1856 and a new dye industry was born. He at first called his discovery Tyrian Purple evoking the value of the ancient, highly expensive, pigment. Other names include aniline purple and Perkin's mauve. Rather than one homogenous molecule, the original mauvine was primarily a mix of four major compounds, mauveine A, mauveine B, mauveine C, and mauveine B2, although there were other mauvine and pseudo mauveines in the dye product.
ISBN 978-0-521-89996-3. Tulard, Jean (1984). Napoleon: The Myth of the Saviour. Methuen. ISBN 978-0-416-39510-5. Upshall, Michael, ed. (1993). The Wordsworth Pocket Encyclopedia. Wordsworth Editions. ISBN 978-1-85326-301-9. White, Matthew (2014), Statistics of Wars, Oppressions and Atrocities of the Nineteenth Century, retrieved 3 May 2017. This source references: Bodart, Gaston (1916), Losses of Life in Modern Wars Dumas, Samuel (1923), Losses of Life Caused By War Urlanis, Boris (1971), Wars and Population Payne, Stanley G., A History of Spain and Portugal, vol. 2 Danzer, Arme-Zeitun (in German) Clodfelter, Micheal, Warfare and Armed Conflict: A Statistical Reference to Casualty and Other Figures, 1618–1991 Young, Peter; Lawford, J. P. (2015). Wellington's Masterpiece: The Battle and Campaign of Salamanca. Routledge. ISBN 978-1-317-39728-1.
Gamma-glutamyltransferase is an enzyme that is overexpressed in cancer, and releases the chelator dithiocarbamate from the prochelator developed by Franz's research group, which forms a toxic copper complex. She works on iron chelators that can be used to remove deleterious iron in brain regions impacted by Parkinson's disease without damaging the healthy metal ions. The chelators developed by Franz have no affinity for iron until a mask is released by hydrogen peroxide, releasing a reactive oxygen species that combines with iron to form hydroxyl radicals. Additionally Franz studies copper-binding peptides such as histatin. Histatin binds to copper in vitro, but it is not clear how they interact or how the anti-fungal activity is modified. The Franz group have studied the anti-fungal activity of Histatin-5 against Candida albicans.
Tangeretin is an O-polymethoxylated flavone that is found in tangerine and other citrus peels. Tangeretin strengthens the cell wall and acts as a plant's defensive mechanism against disease-causing pathogens. It has also been used as a marker compound to detect contamination in citrus juices. The following is a list of methods used to extract tangeretin from citrus peels:
Sources: en.wikipedia.org
Barrel-ageing (US: Barrel aging) is the process of ageing beer in wooden barrels to achieve a variety of effects in the final product. Sour beers such as lambics are fully fermented in wood, while other beers are aged in barrels which were previously used for maturing wines or spirits. In 2016 "Craft Beer and Brewing" wrote: "Barrel-aged beers are so trendy that nearly every taphouse and beer store has a section of them.
South Korean president Lee Jae Myung criticized the campaign via X, stating that it insulted the victims and the residents of Gwangju. Starbucks Korea apologized and its CEO, Son Jeong-Hyun, was fired. Starbucks Korea planned to shutter all its stores in South Korea for half a day on June 22 for its staff to attend a history lesson to increase historical awareness and social sensitivities.
== Applications == The aldehyde tag is a technique which recently found increased application because of the introduction of bioorthogonal chemical reporters. Bioorthogonal agents contain functional groups such as azides or cyclooctynes for coupling which are not naturally found in the cell. Due to their foreignness, they seem inert and do not disrupt the native metabolism, Fig. 3 gives an overview of possible labeling methods for formylglycine. For example, it can be coupled to probes such as biotin or a protein tag like Flag that are useful for purification and detection. Furthermore, fluorophores can be directly conjugated for live cell imaging. The conjugation of polyethylene glycol (PEG) chains to potential drug candidates extends the stability against proteases in body fluids and at the same time reduces renal clearance and immunogenicity. The first application described here, deals with the formation of protein-protein conjugates through bioorthogonal probes. Since, the aldehyde tag is strictly speaking not a true bioorthogonal agent as it can be found in various metabolites, it can cause cross reactions during protein labeling. However, coupling bioorthogonal probes such as azides or cyclooctynes can be applied to overcome this obstacle. As a second application, the coupling of glycan moieties to proteins is presented here. It can be utilised in the strategy of chemically introduced glycosylation patterns.
=== Phase out of single-use plastic straws === On July 9, 2018, Starbucks President and CEO Kevin Johnson announced that Starbucks would phase out the single-use plastic straws by January 1, 2020, on all cold drinks from all locations worldwide due to climate change concerns, pollution, and sea turtle endangerment as the single-use plastic straws failed to be designed for recycling when they were invented. Frappucinos would get straws made from a different material that is sustainable and environmentally friendly such as paper or compostable plastic, while other cold drinks would get straw-less lids. These new modified lids contain 9% less plastic than Starbucks' previous flat lid. The Starbucks locations in Europe, China, Taiwan, Japan, Thailand, Vietnam, India, Canada, Hawaii, Alaska, Washington D.C., New Mexico, California, New York, Washington State, New Jersey, Oregon, Maryland, Delaware, Vermont, Massachusetts, Connecticut, and Rhode Island already eliminated single-use plastic straws by the end of 2018. South Korea is the first country to introduce paper straws to all stores among 78 countries in the world that Starbucks has entered.
Lucijan Marija Škerjanc, Slovene composer, conductor, pianist and musicologist Javad Tabatabai, Iranian philosopher and political scientist, Professor and Vice-Dean of the Faculty of Law and Political Science at the University of Tehran Marek Tamm, Estonian medievalist historian at Tallinn University Buddy Wentworth, Namibian deputy education minister, for his contributions to the Namibian independence struggle Kathryn (Katy) Sheely Wheelock, American educator of the French language, Executive Council Regional Representative & Vice President of the American Association of Teachers of French (2017-2024), founder of Vive Frank White, L.L.D., 8th Governor of North Dakota and 25th Treasurer of the United States. Tengku Zatashah, princess of Selangor and the president of Alliance Française de Kuala Lumpur. Shi Zhengli, virologist and Director of the Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences.
Sources: en.wikipedia.org
=== Paint === Because of its low solubility in water (8 ppm at neutral pH), zinc pyrithione is suitable for use in outdoor paints and other products that protect against mildew and algae. It is an algaecide. It is chemically incompatible with paints relying on metal carboxylate curing agents. When it is used in latex paints with water containing much iron, a sequestering agent that preferentially binds the iron ions is needed. It is decomposed by ultraviolet light slowly, providing years of protection in direct sunlight.
The enzyme can also act on putrescine, which has one extra CH2 in the diamine component, to give carboxyspermidine. Vibrio cholerae uses this enzyme in combination with carboxynorspermidine decarboxylase to make spermidine and norspermidine. This sequence is the dominant pathway to spermidine used by gut microbiota in humans.
It was inspired by the documentary Bond Girls Are Forever, which she produced with Planetgrande, featuring d'Abo and other Bond girls, including Ursula Andress, Honor Blackman, Jill St. John, Maud Adams, Lois Chiles, Judi Dench, Rosamund Pike, Eva Green, Halle Berry, and Carey Lowell. The documentary appeared on the American AMC network in 2002, timed to coincide with the theatrical release of Die Another Day. It was later included as a gift with the purchase of Die Another Day on DVD by some retailers. In 2006, a new version of the documentary, updated to include interviews with cast from Casino Royale (2006) was again aired on the AMC network and later released as a bonus feature on the March 2007 Blu-ray disc and DVD release of Casino Royale. In 2004 she wrote and, with Cabin Creek Films, co-produced the documentary film Bearing Witness, about five female war reporters featuring Marie Colvin and Janine di Giovanni, which Barbara Kopple and Marijana Wotton directed for A&E. The feature documentary premiered at the Tribeca Film Festival. In 2007, she had surgery for a brain hemorrhage; after recovering, she was inspired to meet other people who had similar experiences. She then worked on and produced a 2011 documentary on the topic titled Rupture: A Matter of Life and Death. In 2009, she had a supporting role in the British period fantasy-thriller Dorian Gray. She appeared in the 2014 Indian film Tigers directed by Danis Tanovic, and made her return to the horror genre in 2025 with the British film The Baby in the Basket. D'Abo is signed to Models 1.
The company's earliest stores included its original site in Rittenhouse Square as well as its New York City, Chicago, and Washington, D.C. locations. Locations in New York were opened in 2007 and 2009 in Tribeca and SoHo, respectively. The first location in Chicago was opened in 2011. The second Philadelphia location was opened in Dilworth Park (near Philadelphia City Hall) in 2011. In 2013, the company operated three locations in Seoul, South Korea. Headquarters moved to a new construction in Fishtown, Philadelphia in 2015. The construction had been voted on by residents in 2013. The same year, the company announced plans to expand to 150 new locations in the next three to four years. Expansion to Boston began in September 2015. Expansion to Los Angeles was announced in early 2016, with locations in Beverly Hills and Silver Lake. New locations in Chinatown, Washington, D.C. and Lincoln Park, Chicago were announced in 2016. In San Diego, a new location opened in Westfield UTC in fall 2017. In 2021, a location was announced in Austin, Texas inside a Whole Foods Market, the company's first Texas location. In 2025, both locations in Boston closed (at 745 Atlantic Ave. in Leather District and at 29 Northern Ave. in the Seaport District), with the owners citing financial performance of the locations and other factors. As of 2025, La Colombe advertises on its website 30 locations in the United States, in Philadelphia, New York City, Washington, D.C., Boston, Chicago, Austin, Los Angeles, and San Diego.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.